212 related articles for article (PubMed ID: 31553471)
1. Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial.
Usher NT; Chang S; Howard RS; Martinez A; Harrison LH; Santosham M; Aronson NE
JAMA Netw Open; 2019 Sep; 2(9):e1912014. PubMed ID: 31553471
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study.
Aronson NE; Santosham M; Comstock GW; Howard RS; Moulton LH; Rhoades ER; Harrison LH
JAMA; 2004 May; 291(17):2086-91. PubMed ID: 15126436
[TBL] [Abstract][Full Text] [Related]
3. BCG vaccination among Canadian Indians and Inuit: the epidemiological bases for policy decision.
Young TK
Can J Public Health; 1985; 76(2):124-9. PubMed ID: 4005772
[TBL] [Abstract][Full Text] [Related]
4. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
Glynn JR; Dube A; Fielding K; Crampin AC; ; Kanjala C; Fine PEM
Lancet Infect Dis; 2021 Nov; 21(11):1590-1597. PubMed ID: 34237262
[TBL] [Abstract][Full Text] [Related]
5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
7. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Tameris M; Mearns H; Penn-Nicholson A; Gregg Y; Bilek N; Mabwe S; Geldenhuys H; Shenje J; Luabeya AKK; Murillo I; Doce J; Aguilo N; Marinova D; Puentes E; Rodríguez E; Gonzalo-Asensio J; Fritzell B; Thole J; Martin C; Scriba TJ; Hatherill M;
Lancet Respir Med; 2019 Sep; 7(9):757-770. PubMed ID: 31416768
[TBL] [Abstract][Full Text] [Related]
8. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
[TBL] [Abstract][Full Text] [Related]
9. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
11. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Tameris MD; Hatherill M; Landry BS; Scriba TJ; Snowden MA; Lockhart S; Shea JE; McClain JB; Hussey GD; Hanekom WA; Mahomed H; McShane H;
Lancet; 2013 Mar; 381(9871):1021-8. PubMed ID: 23391465
[TBL] [Abstract][Full Text] [Related]
15. BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial.
Stensballe LG; Ravn H; Birk NM; Kjærgaard J; Nissen TN; Pihl GT; Thøstesen LM; Greisen G; Jeppesen DL; Kofoed PE; Pryds O; Sørup S; Aaby P; Benn CS
J Pediatric Infect Dis Soc; 2019 Jul; 8(3):213-220. PubMed ID: 29635419
[TBL] [Abstract][Full Text] [Related]
16. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
17. BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS; Roth A; Garly ML; Fisker AB; Schaltz-Buchholzer F; Timmermann A; Berendsen M; Aaby P
J Intern Med; 2020 Dec; 288(6):614-624. PubMed ID: 32301189
[TBL] [Abstract][Full Text] [Related]
18. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.
Glynn JR; Fielding K; Mzembe T; Sichali L; Banda L; McLean E; Kanjala C; Crampin AC; Ponnighaus JM; Warndorff DK; Fine PEM;
Lancet Glob Health; 2021 Oct; 9(10):e1451-e1459. PubMed ID: 34534489
[TBL] [Abstract][Full Text] [Related]
19. Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study.
Dehghani K; Lan Z; Li P; Michelsen SW; Waites S; Benedetti A; Lejeune P; Torrie J; Robinson E; Vejvoda B; Mullah M; Redwood D; Cooper M; Fanning A; Yacoub W; Alvarez GG; Søborg B; Long R; Menzies D
Lancet Public Health; 2018 Mar; 3(3):e133-e142. PubMed ID: 29426597
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
